Clark Dermatology Llc

CLIA Laboratory Citation Details

2
Total Citations
12
Total Deficiencyies
6
Unique D-Tags
CMS Certification Number 31D2220087
Address 469 Morris Avenue, Elizabeth, NJ, 07208
City Elizabeth
State NJ
Zip Code07208
Phone(908) 512-7900

Citation History (2 surveys)

Survey - February 28, 2024

Survey Type: Standard

Survey Event ID: P9IC11

Deficiency Tags: D2000 D5217 D5417 D6076 D6091 D2000 D5217 D5417 D6076 D6091

Summary:

Summary Statement of Deficiencies D2000 ENROLLMENT AND TESTING OF SAMPLES CFR(s): 493.801 Each laboratory must enroll in a proficiency testing (PT) program that meets the criteria in subpart I of this part and is approved by HHS. The laboratory must enroll in an approved program or programs for each of the specialties and subspecialties for which it seeks certification. The laboratory must test the samples in the same manner as patients' specimens. For laboratories subject to 42 CFR part 493 published on March 14, 1990 (55 FR 9538) prior to September 1, 1992, the rules of this subpart are effective on September 1, 1992. For all other laboratories, the rules of this subpart are effective January 1, 1994. This CONDITION is not met as evidenced by: Based on surveyor review of the Proficiency Testing (PT) records and interview with the Testing Personnel (TP), the laboratory failed to enroll in an approved PT program for Gram Stain tests in the calender year 2023. The TP confirmed on at 1:40 pm the laboratory was not enrolled in PT for Gram Stain tests. D5217 EVALUATION OF PROFICIENCY TESTING PERFORMANCE CFR(s): 493.1236(c)(1) At least twice annually, the laboratory must verify the accuracy of any test or procedure it performs that is not included in subpart I of this part. This STANDARD is not met as evidenced by: Based on the lack of Biannual Assessment (BA) records and interview with the Testing Personnel (TP), the laboratory failed to verify the accuracy of Histopathology testing from 1/20/22 to the date of survey. The TP confirmed on 2/28/24 at 1:30 pm that the laboratory did not perform BA for Histopathology. Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 2 -- D5417 TEST SYSTEMS, EQUIPMENT, INSTRUMENTS, REAGENT CFR(s): 493.1252(d) Reagents, solutions, culture media, control materials, calibration materials, and other supplies must not be used when they have exceeded their expiration date, have deteriorated, or are of substandard quality. This STANDARD is not met as evidenced by: Based on surveyor observation of the Flammable Cabinet and interview with the Testing Personnel (TP), the laboratory used expired 1% Acid Alcohol and Giemsa stain for Acid-Orcein Giemsa (AOG) Histopatholgy testing from 11/30/23 to the date of survey. The findings include: 1) 1% Acid Alcohol lot # 136227 expired 11/30/23. 2) Giemsa Stain # 150966 expired 11/30/23. 3) Approximately 2 patients were run and reported per week. 4) The TP confirmed on 2/28/24 at 1:30 pm that the laboratory used expired reagent. D6076 LABORATORY DIRECTOR CFR(s): 493.1441 The laboratory must have a director who meets the qualification requirements of 493. 1443 of this subpart and provides overall management and direction in accordance with 493.1445 of this subpart. This CONDITION is not met as evidenced by: Based on surveyor review of the Procedure Manual, Proficiency Testing records and interview with the Laboratory Director (LD) failed to provide overall management and direction to the laboratory to ensure that laboratory testing is performed satisfactorily and in compliance with the CLIA regulations from 1/20/22 to the date of the survey. 1. The LD failed to ensure that the laboratory was enrolled in an Centers for Medicare & Medicaid Services (CMS)-approved proficiency testing program for Gram Stain testing. Cross refer to D6091 2. The LD failed to ensure that the laboratory was performing Biannual Assesment (BA) for Histopathology testing. Cross refer to D6091 D6091 LABORATORY DIRECTOR RESPONSIBILITIES CFR(s): 493.1445(e)(4)(iii) The laboratory director must ensure all proficiency testing reports received are reviewed by the appropriate staff to evaluate the laboratory's performance and to identify any problems that require

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - January 20, 2022

Survey Type: Standard

Survey Event ID: GDPK11

Deficiency Tags: D6102 D6102

Summary:

Summary Statement of Deficiencies D6102 LABORATORY DIRECTOR RESPONSIBILITIES CFR(s): 493.1445(e)(12) The laboratory director must ensure that prior to testing patients' specimens, all personnel have the appropriate education and experience, receive the appropriate training for the type and complexity of the services offered, and have demonstrated that they can perform all testing operations reliably to provide and report accurate results. This STANDARD is not met as evidenced by: Based on surveyor review of Personnel Records (PR) and interview with the Regional Manager (RM), the Laboratory Director failed to ensure that the education records were available on the date of the survey. The finding includes: 1. Education records were not available for two of four Testing Personnel (TP). 2. The RM confirmed on 1 /20/22 at 11:00 am that education records were not available. Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 1 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access